Cargando…
White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer’s disease (AD) neuropathology: A hypothesis and review
We postulate that myelin injury contributes to cholesterol release from myelin and cholesterol dysmetabolism which contributes to Abeta dysmetabolism, and combined with genetic and AD risk factors, leads to increased Abeta and amyloid plaques. Increased Abeta damages myelin to form a vicious injury...
Autores principales: | Sharp, Frank R., DeCarli, Charles S., Jin, Lee-Way, Zhan, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950279/ https://www.ncbi.nlm.nih.gov/pubmed/36845656 http://dx.doi.org/10.3389/fnagi.2023.1096206 |
Ejemplares similares
-
Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities
por: Kalheim, Lisa Flem, et al.
Publicado: (2016) -
Reduced white matter microstructural integrity in prediabetes: Is early glucose dysmetabolism the culprit?
por: Huang, Peiyu, et al.
Publicado: (2022) -
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
por: Staurenghi, Erica, et al.
Publicado: (2021) -
Dysmetabolism and Neurodegeneration: Trick or Treat?
por: Capucho, Adriana M., et al.
Publicado: (2022) -
Clinical significance of cardiovascular dysmetabolic syndrome
por: Deedwania, Prakash C
Publicado: (2002)